STOCK TITAN

Assure Holdings Closes Sale of Certain Assets to MPOWERHealth

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Assure Holdings Corp. (NASDAQ: IONM) announced the sale of certain assets of its IONM business to MPOWERHealth for up to $4.5 million, with $2.32 million paid at closing and a potential earnout of $2.18 million tied to case volume. The sale includes healthcare contracts, clinical equipment, and most employees, while retaining assets like accounts receivable and revenue cycle management team.
Positive
  • None.
Negative
  • None.

The divestiture of Assure Holdings' IONM business segment to MPOWERHealth represents a strategic reallocation of resources, which could potentially streamline operations and refocus the company's core competencies. The upfront cash payment of $2.32 million enhances liquidity, providing immediate capital that could be redeployed for debt reduction or investment in growth initiatives. The contingent earnout of up to $2.18 million, based on case volume, introduces a performance-based element to the transaction, aligning future payments with the success of the transferred assets.

Investors should monitor the company's use of the proceeds for signs of effective capital management. Additionally, the retention of accounts receivable suggests a calculated approach to maintain cash flow continuity. The impact on the stock price will likely depend on the market's perception of the sale's ability to improve Assure's financial health and strategic focus.

In the context of the healthcare industry, the sale of IONM assets by Assure to MPOWERHealth may signal a consolidation trend within the sector. By offloading a significant portion of its clinical equipment and healthcare facility contracts, Assure is likely aiming to refine its service offerings. This could be a response to market pressures such as rising costs or increased competition.

For stakeholders, the realignment could mean a more robust positioning in Assure's remaining business areas. However, the transfer of a majority of employees could also indicate a shift in the company's expertise and service delivery model. The long-term success of this strategy will depend on Assure's ability to capitalize on its retained assets and the growth performance of the IONM market segment post-acquisition.

The intraoperative neuromonitoring sector is highly specialized and the sale of such assets by Assure Holdings to a focused entity like MPOWERHealth could lead to enhanced service quality and operational efficiencies. The transaction may allow MPOWERHealth to leverage economies of scale and potentially improve bargaining power with healthcare facilities.

For Assure, divesting these assets could indicate a strategic pivot or a move to address balance sheet concerns. The retention of the revenue cycle management team points to an emphasis on optimizing revenue streams post-sale. Industry observers should assess whether this move allows Assure to better compete with industry giants or if it signals a retreat from a niche market.

DENVER, March 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, today announced that it closed the sale of certain assets of its IONM business to MPOWERHealth on March 26, 2024. The sale includes proceeds of up to $4.5 million, of which $2.32 million was paid in cash at the initial closing and up to an additional $2.18 million to be paid in relation to a potential earnout payment tied to case volume from the acquired assets during the 12-month period following the initial closing. The asset sale includes most of the Company’s healthcare facility contracts and clinical equipment, and a majority of the Company’s employees. The Company retains certain of its assets, including but not limited to, its accounts receivable and its employees in the revenue cycle management team.

About Assure Holdings

Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.

About MPOWERHealth

Based in Addison, Texas, MPOWERHealth serves more than 400 physicians, 55,000-plus patients and over 300 facilities in 24 states. MPOWERHealth is dedicated to empowering better healthcare through innovative solutions for specialty physicians, hospitals, and payors. Its services include an integrated physician network that supports collaboration between neuromusculoskeletal physicians to promote quality improvements; best-in-class neuromonitoring services for physicians, hospitals, health systems and medical facilities; and bundled solutions for payors that create direct access to the highest level of conservative spine care at a set cost.

Cautionary Statements Regarding Forward-Looking Statements

This press release contains forward-looking statements based upon the current expectations of Assure. Forward-looking statements involve risks and uncertainties and include, but are not limited to, statements regarding the potential for the Company to earn an earnout payment, and other statements that are not historical fact. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation risks related to Assure’s ability to manage its operating expenses; risks related to the market price of Assure’s common stock; and potential adverse reactions or changes to business relationships resulting from the completion of the sales transactions. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. These and other risks and uncertainties are more fully described in periodic filings with the SEC, including the factors described in the section titled “Risk Factors” in Assure’s Annual Report on Form 10-K for the year ended December 31, 2022 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 filed with the SEC, and in other filings that Assure makes and will make with the SEC You should not place undue reliance on these forward-looking statements, which are made only as of the date hereof or as of the dates indicated in the forward-looking statements. Except as required by law, Assure expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Contacts
Brett Maas, Managing Principal
Hayden IR
ionm@haydenir.com
(646) 536-7331


FAQ

What assets did Assure Holdings Corp. sell to MPOWERHealth?

Assure Holdings Corp. sold certain assets of its IONM business to MPOWERHealth, including healthcare facility contracts, clinical equipment, and a majority of its employees.

How much did Assure Holdings Corp. receive from the asset sale?

Assure Holdings Corp. received proceeds of up to $4.5 million from the asset sale, with $2.32 million paid in cash at the initial closing and up to an additional $2.18 million tied to a potential earnout payment based on case volume.

What assets did Assure Holdings Corp. retain after the sale?

Assure Holdings Corp. retained certain assets post-sale, including accounts receivable and its employees in the revenue cycle management team.

Assure Holdings Corp.

NASDAQ:IONM

IONM Rankings

IONM Latest News

IONM Stock Data

4.44M
6.62M
1.21%
2.08%
3.44%
Dental Laboratories
Manufacturing
Link
United States of America
GREENWOOD VILLAGE

About IONM

assure neuromonitoring is a colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. while assure focuses primarily on supporting spinal and vascular surgeries, plans are in place to support other classes of medicine that rely on the standard of care that intraoperative neuromonitoring provides. assure neuromonitoring is committed to delivering the highest quality service in the industry. our patient driven focus is at the core of our organization and is impressed upon all stakeholders. assure employs the highest quality technologists and support staff in the field, thus instilling continuity, reliability and confidence for bot